DKSH stock ahead of the Xetra open with prior close of EUR 74.10 on October 5, 2026
Published on 10/06/2026 at 08:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
DKSH stock was at a prior close of EUR 74.10 at Lang & Schwarz on October 5, 2026, ahead of the Xetra open on October 6, 2026. The quote showed no current pre-market indication.
Before the Xetra open
The prior close at Lang & Schwarz was EUR 74.10 on October 5, 2026. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of DKSH stock.
Expanded healthcare partnership
DKSH Business Unit Healthcare and Grünenthal announced a new regional partnership agreement on September 28, 2026. The agreement covers the commercialization of four medicines—Qutenza, Vimovo, Palexia and Zomig—in up to eight Asia-Pacific markets: Hong Kong, Indonesia, Malaysia, the Philippines, Singapore, Taiwan, Thailand and Vietnam, according to the EQS Group release.
Under the agreement, DKSH will support local marketing authorizations, marketing, medical affairs, market access, sales and distribution for the medicines, subject to local regulatory approvals. Grünenthal will manufacture the products, its announcement said.
Partnership background
The companies said the new agreement builds on a partnership established in 2023. Under the expanded arrangement, DKSH will seek local marketing authorizations for the four medicines across the participating markets, with Zomig also being introduced in additional markets not covered by the earlier agreement.
